Works matching AU Tae-Min Kim

Results: 310
    1

    Superior Treatment Response and In-field Tumor Control in Epidermal Growth Factor Receptor-mutant Genotype of Stage III Nonsquamous Non-Small cell Lung Cancer Undergoing Definitive Concurrent Chemoradiotherapy.

    Published in:
    2017
    By:
    • Yu Jin Lim;
    • Ji Hyun Chang;
    • Hak-Jae Kim;
    • Keam, Bhumsuk;
    • Tae Min Kim;
    • Dong-Wan Kim;
    • Jin Chul Paeng;
    • Keon Wook Kang;
    • June-Key Chung;
    • Yoon Kyung Jeon;
    • Doo Hyun Chung;
    • Hong-Gyun Wu;
    • Lim, Yu Jin;
    • Chang, Ji Hyun;
    • Kim, Hak-Jae;
    • Kim, Tae Min;
    • Kim, Dong-Wan;
    • Paeng, Jin Chul;
    • Kang, Keon Wook;
    • Chung, June-Key
    Publication type:
    journal article
    2
    3

    Serum Neuron-Specific Enolase Levels Predict the Efficacy of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations.

    Published in:
    2016
    By:
    • Koung Jin Suh;
    • Bhumsuk Keam;
    • Miso Kim;
    • Young Sik Park;
    • Tae Min Kim;
    • Yoon Kyung Jeon;
    • Dong-Wan Kim;
    • Doo Hyun Chung;
    • Young Whan Kim;
    • Dae Seog Heo;
    • Suh, Koung Jin;
    • Keam, Bhumsuk;
    • Kim, Miso;
    • Park, Young Sik;
    • Kim, Tae Min;
    • Jeon, Yoon Kyung;
    • Kim, Dong-Wan;
    • Chung, Doo Hyun;
    • Kim, Young Whan;
    • Heo, Dae Seog
    Publication type:
    journal article
    4

    MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system.

    Published in:
    2016
    By:
    • Sehui Kim;
    • Soo Jeong Nam;
    • Dohee Kwon;
    • Hannah Kim;
    • Eunyoung Lee;
    • Tae Min Kim;
    • Dae Seog Heo;
    • Sung Hye Park;
    • Chul Woo Kim;
    • Yoon Kyung Jeon;
    • Kim, Sehui;
    • Nam, Soo Jeong;
    • Kwon, Dohee;
    • Kim, Hannah;
    • Lee, Eunyoung;
    • Kim, Tae Min;
    • Heo, Dae Seog;
    • Park, Sung Hye;
    • Kim, Chul Woo;
    • Jeon, Yoon Kyung
    Publication type:
    journal article
    5
    6

    Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study.

    Published in:
    2016
    By:
    • Ryul Kim;
    • Chan-Young Ock;
    • Bhumsuk Keam;
    • Tae Min Kim;
    • Jin Ho Kim;
    • Jin Chul Paeng;
    • Seong Keun Kwon;
    • Hah, J. Hun;
    • Tack-Kyun Kwon;
    • Dong-Wan Kim;
    • Hong-Gyun Wu;
    • Myung-Whun Sung;
    • Dae Seog Heo;
    • Kim, Ryul;
    • Ock, Chan-Young;
    • Keam, Bhumsuk;
    • Kim, Tae Min;
    • Kim, Jin Ho;
    • Paeng, Jin Chul;
    • Kwon, Seong Keun
    Publication type:
    journal article
    7

    Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP‐005 study recurrent glioblastoma cohort.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 16, p. 1, doi. 10.1002/cncr.70015
    By:
    • Rha, Sun Young;
    • Castanon, Eduardo;
    • Gill, Sanjeev;
    • Senellart, Helene;
    • Lopez, Juanita;
    • Márquez‐Rodas, Iván;
    • Victoria, Iván;
    • Kim, Tae Min;
    • Lwin, Zarnie;
    • Burger, Michael C.;
    • Simonelli, Matteo;
    • Cassier, Philippe A.;
    • Hendifar, Andrew E.;
    • Ascierto, Paolo A.;
    • Dutcus, Corina;
    • Okpara, Chinyere E.;
    • Ghori, Razi;
    • Jin, Fan;
    • Groisberg, Roman;
    • Villanueva, Luis
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Multi- targeted therapy resistance via drug- induced secretome fucosylation.

    Published in:
    eLife, 2023, p. 1, doi. 10.7554/eLife.75191
    By:
    • Mark Borris D. Aldonza;
    • Junghwa Cha;
    • Insung Yong;
    • Jayoung Ku;
    • Pavel Sinitcyn;
    • Dabin Lee;
    • Ryeong- Eun Cho;
    • Roben D. Delos Reyes;
    • Dongwook Kim;
    • Soyeon Kim;
    • Minjeong Kang;
    • Yongsuk Ku;
    • Geonho Park;
    • Hye- Jin Sung;
    • Han Suk Ryu;
    • Sukki Cho;
    • Tae Min Kim;
    • Pilnam Kim;
    • Je- Yoel Cho;
    • Yoosik Kim
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    PB2343: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS STANDARD OF CARE THERAPY IN RELAPSED/REFRACTORY AGGRESSIVE B‐CELL NON‐HODGKIN LYMPHOMA (OLYMPIA‐4)

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000976092.30614.25
    By:
    • Hawkes, Eliza A.;
    • Kim, Tae Min;
    • Namuduri, Manjusha;
    • Risal, Ashish;
    • Shen, Biyi;
    • Flink, Dina;
    • Zhu, Min;
    • Nolan, Siobhán;
    • Brouwer‐Visser, Jurriaan;
    • Chaudhry, Aafia;
    • Ambati, Srikanth;
    • Mohamed, Hesham;
    • Cho, Seok‐Goo
    Publication type:
    Article
    33
    34

    PB2267: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA (OLYMPIA‐1)

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000975800.84791.f4
    By:
    • Luminari, Stefano;
    • Kim, Tae Min;
    • Risal, Ashish;
    • Namuduri, Manjusha;
    • Cai, Jingxian;
    • Fearon‐Chalet, Bertha;
    • Zhu, Min;
    • Mukherjee, Sushmita;
    • Brouwer‐Visser, Jurriaan;
    • Chaudhry, Aafia;
    • Mohamed, Hesham;
    • Ambati, Srikanth;
    • Vitolo, Umberto
    Publication type:
    Article
    35
    36
    37
    38

    A Randomized, Multicenter, Phase II Study of Cetuximab With Docetaxel and Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck Cancer.

    Published in:
    Oncologist, 2015, v. 20, n. 10, p. 1119, doi. 10.1634/theoncologist.2015-0208
    By:
    • Lee, Keun‐Wook;
    • Koh, Youngil;
    • Kim, Sung‐Bae;
    • Shin, Sang‐Won;
    • Kang, Jin‐Hyoung;
    • Wu, Hong‐Gyun;
    • Sung, Myung‐Whun;
    • Keam, Bhumsuk;
    • Kim, Dong‐Wan;
    • Kim, Tae Min;
    • Kim, Kwang Hyun;
    • Kwon, Tack‐Kyun;
    • Hah, J. Hun;
    • Kim, In‐Ah;
    • Ahn, Soon‐Hyun;
    • Yoon, Dok Hyun;
    • Lee, Sang‐Wook;
    • Kim, Sang Yoon;
    • Nam, Soon Yuhl;
    • Jung, Kwang‐Yoon
    Publication type:
    Article
    39

    Clinical Trial Results. A Phase II Study of Ifosfamide, Methotrexate, Etoposide, and Prednisolone for Previously Untreated Stage I/II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of the Korean Cancer Study Group.

    Published in:
    Oncologist, 2014, v. 19, n. 11, p. 1128, doi. 10.1634/theoncologist.2014-0305
    By:
    • Kim, Tae Min;
    • Kim, Dong‐Wan;
    • Kang, Yoon‐Koo;
    • Chung, Jooseop;
    • Song, Hong‐Suk;
    • Kim, Hyo Jung;
    • Kim, Byung Soo;
    • Lee, Jong‐Seok;
    • Kim, Hawk;
    • Yang, Sung Hyun;
    • Yuh, Young Jin;
    • Bae, Sung Hwa;
    • Hyun, Myung Soo;
    • Jeon, Yoon Kyung;
    • Kim, Chul Woo;
    • Heo, Dae Seog
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Influence of Concurrent and Adjuvant Temozolomide on Health-Related Quality of Life of Patients with Grade III Gliomas: A Secondary Analysis of a Randomized Clinical Trial (KNOG-1101 Study).

    Published in:
    Cancer Research & Treatment, 2022, v. 54, n. 2, p. 396, doi. 10.4143/crt.2021.393
    By:
    • Ahn, Grace S.;
    • Kihwan Hwang;
    • Tae Min Kim;
    • Chul Kee Park;
    • Jong Hee Chang;
    • Tae-Young Jung;
    • Jin Hee Kim;
    • Do-Hyun Nam;
    • Se-Hyuk Kim;
    • Heon Yoo;
    • Yong-Kil Hong;
    • Eun-Young Kim;
    • Dong-Eun Lee;
    • Jungnam Joo;
    • Yu Jung Kim;
    • Gheeyoung Choe;
    • Byung Se Choi;
    • Seok-Gu Kang;
    • Jeong Hoon Kim;
    • Chae-Yong Kim
    Publication type:
    Article